Establishment Long Term Debt vs Other Current Assets Analysis

ESTA Stock

USD 48.47 0.07 0.14%

Establishment Labs financial indicator trend analysis is much more than just examining Establishment Labs latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Establishment Labs is a good investment. Please check the relationship between Establishment Labs Long Term Debt and its Other Current Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Long Term Debt vs Other Current Assets

Long Term Debt vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Establishment Labs Long Term Debt account and Other Current Assets. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Establishment Labs' Long Term Debt and Other Current Assets is 0.84. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Establishment Labs Holdings, assuming nothing else is changed. The correlation between historical values of Establishment Labs' Long Term Debt and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Establishment Labs Holdings are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Long Term Debt i.e., Establishment Labs' Long Term Debt and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.84

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that Establishment Labs has held for over one year. Long-term debt appears on Establishment Labs Holdings balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Establishment Labs Holdings balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most indicators from Establishment Labs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Establishment Labs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

The current year's Tax Provision is expected to grow to about 3.4 M, whereas Selling General Administrative is forecasted to decline to about 74 M.

	2021	2022	2023	2024 (projected)
Gross Profit	85.4M	106.6M	107.0M	58.1M
Total Revenue	126.7M	161.7M	165.2M	92.0M

Gross Profit Total Revenue

Establishment Labs fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity
Common Stock Shares Outstanding		0.85	0.57	0.64	-0.55	0.7	0.34	0.57	0.57	0.21	0.21	-0.8	0.57	0.82	0.57	0.18	-0.55	0.82	0.82	0.9	0.89	0.71	0.83	0.7	0.68	0.81
Total Assets	0.85		0.78	0.47	-0.44	0.61	0.16	0.42	0.77	0.24	0.45	-0.93	0.74	0.82	0.77	0.42	-0.28	0.82	0.98	0.87	0.96	0.88	0.9	0.84	0.86	0.9
Short Long Term Debt Total	0.57	0.78		0.39	-0.11	0.15	-0.33	-0.13	0.98	0.4	0.89	-0.91	0.93	0.47	0.97	0.8	0.12	0.47	0.81	0.55	0.64	0.97	0.86	0.89	0.8	0.89
Other Current Liab	0.64	0.47	0.39		-0.08	0.25	0.03	0.16	0.38	0.61	0.22	-0.53	0.39	0.44	0.38	0.05	-0.44	0.44	0.5	0.64	0.49	0.45	0.69	0.4	0.43	0.64
Total Current Liabilities	-0.55	-0.44	-0.11	-0.08		-0.88	-0.7	-0.87	-0.11	0.47	0.28	0.37	-0.11	-0.79	-0.11	0.21	0.76	-0.79	-0.35	-0.61	-0.62	-0.31	-0.36	-0.35	-0.26	-0.35
Total Stockholder Equity	0.7	0.61	0.15	0.25	-0.88		0.7	0.94	0.21	-0.26	-0.27	-0.5	0.25	0.86	0.22	-0.09	-0.79	0.86	0.52	0.79	0.77	0.36	0.5	0.48	0.3	0.5
Other Liab	0.34	0.16	-0.33	0.03	-0.7	0.7		0.79	-0.27	-0.2	-0.59	0.04	-0.25	0.43	-0.26	-0.52	-0.85	0.43	0.12	0.51	0.3	-0.12	0.04	0.01	0.05	0.01
Net Tangible Assets	0.57	0.42	-0.13	0.16	-0.87	0.94	0.79		-0.1	-0.38	-0.55	-0.24	-0.07	0.78	-0.09	-0.41	-0.8	0.78	0.32	0.63	0.63	0.1	0.25	0.18	0.15	0.23
Property Plant And Equipment Net	0.57	0.77	0.98	0.38	-0.11	0.21	-0.27	-0.1		0.42	0.88	-0.92	0.98	0.45	1.0	0.86	0.05	0.45	0.8	0.59	0.63	0.96	0.88	0.94	0.74	0.91
Current Deferred Revenue	0.21	0.24	0.4	0.61	0.47	-0.26	-0.2	-0.38	0.42		0.48	-0.29	0.39	-0.04	0.42	0.34	0.08	-0.04	0.29	0.27	0.05	0.33	0.42	0.28	0.42	0.39
Net Debt	0.21	0.45	0.89	0.22	0.28	-0.27	-0.59	-0.55	0.88	0.48		-0.66	0.85	0.01	0.87	0.89	0.42	0.01	0.54	0.19	0.24	0.77	0.61	0.7	0.56	0.65
Retained Earnings	-0.8	-0.93	-0.91	-0.53	0.37	-0.5	0.04	-0.24	-0.92	-0.29	-0.66		-0.91	-0.72	-0.92	-0.63	0.21	-0.72	-0.93	-0.81	-0.87	-0.97	-0.97	-0.95	-0.81	-0.98
Accounts Payable	0.57	0.74	0.93	0.39	-0.11	0.25	-0.25	-0.07	0.98	0.39	0.85	-0.91		0.41	0.99	0.88	-0.01	0.41	0.78	0.6	0.61	0.92	0.87	0.96	0.63	0.9
Cash	0.82	0.82	0.47	0.44	-0.79	0.86	0.43	0.78	0.45	-0.04	0.01	-0.72	0.41		0.45	0.03	-0.57	1.0	0.72	0.83	0.92	0.64	0.71	0.59	0.66	0.7
Non Current Assets Total	0.57	0.77	0.97	0.38	-0.11	0.22	-0.26	-0.09	1.0	0.42	0.87	-0.92	0.99	0.45		0.86	0.04	0.45	0.8	0.6	0.63	0.96	0.88	0.95	0.73	0.91
Non Currrent Assets Other	0.18	0.42	0.8	0.05	0.21	-0.09	-0.52	-0.41	0.86	0.34	0.89	-0.63	0.88	0.03	0.86		0.37	0.03	0.46	0.19	0.23	0.69	0.55	0.76	0.35	0.61
Other Assets	-0.55	-0.28	0.12	-0.44	0.76	-0.79	-0.85	-0.8	0.05	0.08	0.42	0.21	-0.01	-0.57	0.04	0.37		-0.57	-0.24	-0.69	-0.45	-0.09	-0.34	-0.23	-0.09	-0.3
Cash And Short Term Investments	0.82	0.82	0.47	0.44	-0.79	0.86	0.43	0.78	0.45	-0.04	0.01	-0.72	0.41	1.0	0.45	0.03	-0.57		0.72	0.83	0.92	0.64	0.71	0.59	0.66	0.7
Net Receivables	0.82	0.98	0.81	0.5	-0.35	0.52	0.12	0.32	0.8	0.29	0.54	-0.93	0.78	0.72	0.8	0.46	-0.24	0.72		0.85	0.92	0.9	0.91	0.86	0.86	0.91
Good Will	0.9	0.87	0.55	0.64	-0.61	0.79	0.51	0.63	0.59	0.27	0.19	-0.81	0.6	0.83	0.6	0.19	-0.69	0.83	0.85		0.9	0.72	0.87	0.77	0.69	0.85
Common Stock Total Equity	0.89	0.96	0.64	0.49	-0.62	0.77	0.3	0.63	0.63	0.05	0.24	-0.87	0.61	0.92	0.63	0.23	-0.45	0.92	0.92	0.9		0.78	0.85	0.76	0.76	0.84
Non Current Liabilities Total	0.71	0.88	0.97	0.45	-0.31	0.36	-0.12	0.1	0.96	0.33	0.77	-0.97	0.92	0.64	0.96	0.69	-0.09	0.64	0.9	0.72	0.78		0.94	0.93	0.85	0.95
Capital Surpluse	0.83	0.9	0.86	0.69	-0.36	0.5	0.04	0.25	0.88	0.42	0.61	-0.97	0.87	0.71	0.88	0.55	-0.34	0.71	0.91	0.87	0.85	0.94		0.92	0.81	1.0
Inventory	0.7	0.84	0.89	0.4	-0.35	0.48	0.01	0.18	0.94	0.28	0.7	-0.95	0.96	0.59	0.95	0.76	-0.23	0.59	0.86	0.77	0.76	0.93	0.92		0.68	0.94
Other Current Assets	0.68	0.86	0.8	0.43	-0.26	0.3	0.05	0.15	0.74	0.42	0.56	-0.81	0.63	0.66	0.73	0.35	-0.09	0.66	0.86	0.69	0.76	0.85	0.81	0.68		0.79
Other Stockholder Equity	0.81	0.9	0.89	0.64	-0.35	0.5	0.01	0.23	0.91	0.39	0.65	-0.98	0.9	0.7	0.91	0.61	-0.3	0.7	0.91	0.85	0.84	0.95	1.0	0.94	0.79

Click cells to compare fundamentals

Establishment Labs Account Relationship Matchups

Establishment Labs fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	20.5M	23.3M	24.0M	24.5M	25.6M	21.8M
Total Assets	116.5M	156.4M	139.5M	211.1M	268.6M	150.6M
Short Long Term Debt Total	48.1M	51.8M	53.8M	178.7M	192.2M	201.8M
Other Current Liab	11.8M	14.0M	16.2M	16.5M	12.9M	14.5M
Total Current Liabilities	23.2M	25.9M	31.9M	39.0M	57.2M	30.6M
Total Stockholder Equity	39.6M	75.0M	50.7M	(8.2M)	18.4M	29.4M
Other Liab	5.5M	3.8M	3.1M	1.6M	1.5M	1.4M
Net Tangible Assets	35.7M	70.3M	45.9M	(13.3M)	(15.2M)	(14.5M)
Property Plant And Equipment Net	16.4M	18.8M	20.9M	54.8M	80.6M	84.6M
Current Deferred Revenue	785K	1.2M	769K	1.7M	1.8M	1.5M
Net Debt	10.5M	(32.8M)	391K	112.3M	152.2M	159.8M
Retained Earnings	(127.1M)	(165.2M)	(206.4M)	(281.6M)	(360.1M)	(342.1M)
Accounts Payable	10.4M	9.7M	14.5M	20.0M	41.6M	43.7M
Cash	37.7M	84.5M	53.4M	66.4M	40.0M	47.6M
Non Current Assets Total	20.7M	24.1M	26.3M	61.2M	93.7M	98.4M
Non Currrent Assets Other	368K	664K	558K	1.3M	4.7M	4.9M
Other Assets	368K	664K	558K	1.3M	1.5M	785.7K
Cash And Short Term Investments	37.7M	84.5M	53.4M	66.4M	40.0M	47.6M
Net Receivables	22.8M	19.1M	24.4M	35.4M	46.9M	25.6M
Common Stock Total Equity	147.7M	213.5M	219.7M	223.6M	257.2M	156.9M
Liabilities And Stockholders Equity	116.5M	156.4M	139.5M	211.1M	268.6M	150.6M
Non Current Liabilities Total	53.7M	55.5M	56.9M	180.3M	193.1M	202.8M
Capital Surpluse	21.2M	26.7M	36.6M	49.9M	57.4M	60.3M
Inventory	28.7M	23.2M	28.4M	36.6M	79.9M	83.9M
Other Current Assets	1.3M	2.6M	2.6M	11.5M	8.0M	4.6M
Other Stockholder Equity	18.4M	23.9M	33.7M	47.1M	60.9M	63.9M
Total Liab	76.9M	81.4M	88.8M	219.2M	250.2M	262.8M
Property Plant And Equipment Gross	16.4M	18.8M	20.9M	54.8M	96.9M	101.8M
Total Current Assets	95.8M	132.3M	113.3M	149.9M	174.9M	112.4M
Accumulated Other Comprehensive Income	691K	2.9M	3.7M	2.7M	2.0M	1.5M
Non Current Liabilities Other	336K	2.3M	2.4M	175.5M	147K	139.7K
Short Term Debt	258K	948K	402K	688K	773K	734.4K
Intangible Assets	3.4M	4.1M	4.4M	4.6M	8.0M	4.6M
Common Stock	147.7M	213.5M	219.7M	223.6M	315.6M	180.7M
Property Plant Equipment	16.4M	16.2M	20.9M	51.1M	58.8M	61.7M
Long Term Debt	48.1M	49.8M	51.9M	175.5M	188.7M	198.2M
Net Invested Capital	87.8M	124.8M	102.6M	175.5M	207.1M	127.1M
Net Working Capital	72.6M	106.4M	81.4M	110.9M	117.8M	87.1M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Establishment Labs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Establishment Labs' short interest history, or implied volatility extrapolated from Establishment Labs options trading.

Pair Trading with Establishment Labs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Establishment Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Establishment Labs will appreciate offsetting losses from the drop in the long position's value.

Moving against Establishment Stock

0.8	GH	Guardant Health Financial Report 14th of May 2024	Pair Corr
0.69	DNA	Ginkgo Bioworks Holdings Financial Report 8th of May 2024	Pair Corr
0.53	IDXX	IDEXX Laboratories Financial Report 7th of May 2024	Pair Corr
0.46	CTSO	Cytosorbents Crp Financial Report 7th of May 2024	Pair Corr

The ability to find closely correlated positions to Establishment Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Establishment Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Establishment Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Establishment Labs Holdings to buy it.

The correlation of Establishment Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Establishment Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Establishment Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Establishment Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:

How To Invest In Establishment

Details

Is Establishment Stock a good investment?

Details

What is Establishment Labs' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Establishment Stock analysis

When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.

	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios

Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.07)

Revenue Per Share

6.451

Quarterly Revenue Growth

(0.28)

Return On Assets

(0.17)

Return On Equity

(15.38)

The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Establishment Long Term Debt vs Other Current Assets Analysis

Long Term Debt vs Other Current Assets

Long Term Debt vs Other Current Assets Correlation Analysis

Correlation Coefficient

Long Term Debt

Other Current Assets

Establishment Labs fundamental ratios Correlations

Establishment Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Establishment Labs fundamental ratios Accounts

Pair Trading with Establishment Labs

Moving against Establishment Stock

Complementary Tools for Establishment Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Other Stockholder Equity	+ 1.0	Capital Surpluse
Non Current Assets Total	+ 0.99	Accounts Payable
Net Receivables	+ 0.98	Total Assets
Property Plant And Equipment Net	+ 0.98	Short Long Term Debt Total

Other Stockholder Equity	- 0.98	Retained Earnings
Capital Surpluse	- 0.97	Retained Earnings
Non Current Liabilities Total	- 0.97	Retained Earnings
Inventory	- 0.95	Retained Earnings
Net Receivables	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Total Assets